We would like to inform you that the Second Annual Conference on Commercialisation & Market Access Strategies for Orphan & Ultra-Orphan Drugs will take place on 17 February 2011 in Barcelona, Spain. Focusing on orphan and ultra-orphan drugs, this event will provide a fresh perspective on one of the industry’s hottest areas for market & patient access. Communicating value and cost-effectiveness with regulators, payers, HTA bodies and other key stakeholders, in such niche markets, requires innovation and a clearly defined process to ensure the message is achieved. The event will be focused purely on orphan therapies and will guarantee all participants access to today’s most relevant case studies and views which directly affect their future business plans and can assist them to maximise market and patient access. Organiser is NextLevel Pharma. For more detailed information, please visit the official website of the event.
362